Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
Some patients with COVID have abnormally high carbon dioxide and low oxygen levels despite being on the ventilator. The hypothesis of the study is that the application of mild hypothermia to patients with COVID will decrease their metabolic rate and improve their oxygenation and carbon dioxide levels.
Description: indirect calorimeter measurements (Kcal/day)
Measure: Changes in metabolic requirement during and after hypothermia Time: Every 12 hours through study completion an average of 4 daysDescription: ABG, PaO2 (mmHg)
Measure: Changes in oxygen requirements and levels during and after hypothermia Time: Every 12 hours through study completion, an average of 4 daysDescription: number of hours intubated
Measure: length of intubation Time: through study completion, an average of 4 daysDescription: measured by ABG, PaCO2 mmHg
Measure: Changes in carbon dioxide levels during and after hypothermia Time: Every 12 hours through study completion an average of 4 daysDescription: ESR (mm/hr)
Measure: does application of hypothermia reduce pro inflammatory response Time: through study completion an average of 4 daysDescription: Ferritin (ng/ml)
Measure: does application of hypothermia reduce pro inflammatory response Time: through study completion an average of 4 daysDescription: D Dimer (ng/ml)
Measure: does application of hypothermia reduce pro inflammatory response Time: through study completion an average of 4 daysAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports